
|Articles|January 22, 2018
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
2
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
3
What Pharmacists Need to Know as Ebola Cases Climb in the Democratic Republic of the Congo and Uganda
4
Montelukast Prophylaxis Reduces Rituximab Infusion Reactions in Oncology Patients
5





















































































































